End-of-day quote
Shanghai S.E.
23:00:00 28/04/2024 BST
|
5-day change
|
1st Jan Change
|
61.03
CNY
|
+0.98%
|
|
+15.76%
|
-20.17%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
32,875
|
88,663
|
63,807
|
49,055
|
24,513
|
19,569
|
-
|
-
|
Enterprise Value (EV)
1 |
32,773
|
88,275
|
63,240
|
48,594
|
24,327
|
18,586
|
17,486
|
17,526
|
P/E ratio
|
71.2
x
|
180
x
|
90.9
x
|
89.5
x
|
49
x
|
34.5
x
|
23.2
x
|
27
x
|
Yield
|
-
|
-
|
-
|
-
|
0.57%
|
0.09%
|
-
|
-
|
Capitalization / Revenue
|
17.4
x
|
42.5
x
|
22.9
x
|
18
x
|
8.61
x
|
6.32
x
|
4.91
x
|
4.91
x
|
EV / Revenue
|
17.3
x
|
42.3
x
|
22.7
x
|
17.9
x
|
8.55
x
|
6
x
|
4.39
x
|
4.4
x
|
EV / EBITDA
|
45.5
x
|
114
x
|
58.5
x
|
56.4
x
|
28.5
x
|
19.4
x
|
13.9
x
|
15.8
x
|
EV / FCF
|
-
|
-
|
111
x
|
195
x
|
72.7
x
|
33.2
x
|
26.5
x
|
18.9
x
|
FCF Yield
|
-
|
-
|
0.9%
|
0.51%
|
1.38%
|
3.01%
|
3.77%
|
5.3%
|
Price to Book
|
18.4
x
|
41.2
x
|
22.2
x
|
14.8
x
|
6.44
x
|
4.19
x
|
3.51
x
|
-
|
Nbr of stocks (in thousands)
|
320,640
|
320,640
|
320,640
|
320,640
|
320,640
|
320,640
|
-
|
-
|
Reference price
2 |
102.5
|
276.5
|
199.0
|
153.0
|
76.45
|
61.03
|
61.03
|
61.03
|
Announcement Date
|
23/04/20
|
09/04/21
|
27/04/22
|
27/04/23
|
25/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,894
|
2,088
|
2,781
|
2,719
|
2,847
|
3,097
|
3,984
|
3,985
|
EBITDA
1 |
720.2
|
771.5
|
1,081
|
861.6
|
852.4
|
956.3
|
1,259
|
1,111
|
EBIT
1 |
633.8
|
678.6
|
974.9
|
733.9
|
711.9
|
771.5
|
1,150
|
1,010
|
Operating Margin
|
33.46%
|
32.5%
|
35.06%
|
27%
|
25.01%
|
24.91%
|
28.87%
|
25.35%
|
Earnings before Tax (EBT)
1 |
633.4
|
680.1
|
974.6
|
738
|
708.9
|
796.7
|
1,159
|
1,062
|
Net income
1 |
463.1
|
492.6
|
702.8
|
548.3
|
500.5
|
567.5
|
844.8
|
725.1
|
Net margin
|
24.45%
|
23.59%
|
25.27%
|
20.17%
|
17.58%
|
18.32%
|
21.2%
|
18.19%
|
EPS
2 |
1.440
|
1.540
|
2.190
|
1.710
|
1.560
|
1.769
|
2.636
|
2.260
|
Free Cash Flow
1 |
-
|
-
|
572.1
|
249.1
|
334.5
|
559
|
660
|
929
|
FCF margin
|
-
|
-
|
20.57%
|
9.16%
|
11.75%
|
18.05%
|
16.57%
|
23.31%
|
FCF Conversion (EBITDA)
|
-
|
-
|
52.91%
|
28.92%
|
39.24%
|
58.45%
|
52.44%
|
83.61%
|
FCF Conversion (Net income)
|
-
|
-
|
81.4%
|
45.44%
|
66.84%
|
98.5%
|
78.13%
|
128.13%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
0.4350
|
0.0555
|
-
|
-
|
Announcement Date
|
23/04/20
|
09/04/21
|
27/04/22
|
27/04/23
|
25/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
-
|
663.5
|
821.2
|
579.2
|
674.5
|
688.1
|
822.2
|
661.7
|
708.4
|
758.1
|
904.6
|
716.3
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
175.1
|
282
|
51.96
|
225
|
176.8
|
282.4
|
27.71
|
-
|
170.6
|
300.4
|
81.54
|
Operating Margin
|
-
|
26.38%
|
34.34%
|
8.97%
|
33.36%
|
25.69%
|
34.35%
|
4.19%
|
-
|
22.51%
|
33.2%
|
11.38%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
51.38
|
224.7
|
176.2
|
282.1
|
-
|
-
|
-
|
-
|
-
|
Net income
|
166.5
|
-
|
-
|
33.1
|
169
|
135.4
|
207.3
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
5.71%
|
25.05%
|
19.68%
|
25.22%
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.5200
|
0.4000
|
0.6900
|
0.1000
|
0.5300
|
0.4200
|
0.6500
|
-0.0400
|
0.5400
|
0.4200
|
0.7100
|
0.1100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
27/04/22
|
22/08/22
|
24/10/22
|
27/04/23
|
27/04/23
|
24/08/23
|
24/10/23
|
25/04/24
|
25/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
103
|
389
|
568
|
461
|
186
|
982
|
2,083
|
2,043
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
572
|
249
|
335
|
559
|
660
|
929
|
ROE (net income / shareholders' equity)
|
29.9%
|
24.4%
|
27.9%
|
17.6%
|
14.1%
|
13.6%
|
15.7%
|
14.7%
|
ROA (Net income/ Total Assets)
|
19.3%
|
17.1%
|
17.5%
|
10.8%
|
-
|
8.9%
|
9.87%
|
-
|
Assets
1 |
2,396
|
2,877
|
4,010
|
5,055
|
-
|
6,437
|
8,116
|
-
|
Book Value Per Share
2 |
5.570
|
6.710
|
8.980
|
10.30
|
11.90
|
13.90
|
17.00
|
18.70
|
Cash Flow per Share
2 |
2.020
|
2.210
|
2.930
|
2.090
|
2.620
|
2.870
|
3.250
|
-
|
Capex
1 |
126
|
166
|
367
|
421
|
505
|
381
|
248
|
380
|
Capex / Sales
|
6.64%
|
7.94%
|
13.21%
|
15.48%
|
17.76%
|
12.02%
|
6.41%
|
9.09%
|
Announcement Date
|
23/04/20
|
09/04/21
|
27/04/22
|
27/04/23
|
25/04/24
|
-
|
-
|
-
|
Last Close Price
61.03
CNY Average target price
80.8
CNY Spread / Average Target +32.39% Consensus |
1st Jan change
|
Capi.
|
---|
| -20.17% | 2.7B | | -18.39% | 3.02B | | -59.12% | 2.11B | | -25.50% | 321M | | +2.88% | 221M | | -46.12% | 177M | | -27.37% | 123M |
Doctor's Office
|